21.20.0
FАRMАTSEVTIKА PREPАRАTLАRINI ISHLАB CHIQАRISH
152
MAS‘ULIYATI CHEKLANGAN YOKI QO‘SHIMCHA MAS‘ULIYATLI JAMIYAT
03877
O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi huzurida Farmatsevtika tarmog‘ini rivojlantirish agentligi
1726290
Республика Узбекистан, город Ташкент, Яшнободский район
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
Information found about participation in government procurement as a supplier or customer
Supplier
5
Customer
0
Коротко о компании
FITO BIO MAX has been operating since 2021 in the "Производство фармацевтических препаратов" industry. The director is LAPTEV VYACHESLAV SERGEYEVICH. The company belongs to the "Small business" category. Its primary activity is "Производство фармацевтических препаратов". The company has 1 founders, one of whom owns a 100% stake. The company is not engaged in licensed activities.. The company has no registered property., is included in 0, and has 236 similar companies, indicating a developed competitive market.
Stability rating:
Tax debt:
Is a large taxpayer:
Has a license:
Abuses the right to reduce VAT payable:
Is a resident of the IT Park:
Rating of participants in the electronic public procurement system:
Developer rating:
Included in the unified register of unscrupulous performers:
8
3
5
0
No data on licenses
No data on real estate
No data on trademarks
Коротко о компании
FITO BIO MAX has been operating since 2021 in the "Производство фармацевтических препаратов" industry. The director is LAPTEV VYACHESLAV SERGEYEVICH. The company belongs to the "Small business" category. Its primary activity is "Производство фармацевтических препаратов". The company has 1 founders, one of whom owns a 100% stake. The company is not engaged in licensed activities.. The company has no registered property., is included in 0, and has 236 similar companies, indicating a developed competitive market.